Matthew Lee, MD, discusses how confident he is that CEACAM5 expression will hold up as a biomarker for BG-C477 in NSCLC.
Matthew Lee, MD
Advertisement
Articles by Matthew Lee, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Cardiac Assessment With Atrial Fibrillation and Closing Thoughts
2
FDA Receives BLA for Etentamig in Relapsed/Refractory Multiple Myeloma
3
Cisplatin-Free Pembrolizumab Regimen Misses Primary End Point in SMART-KEY
4
Prior ICI Exposure Linked to Higher Dermatitis Risk With Lirafugratinib in FGFR2-Altered Tumors
5